CTRI/2020/12/029822
Recruiting
未知
on-Interventional Study Protocol (non-PASS) with secondary use of data To understand the characteristics, treatment patterns and outcomes in nAMD across various centers in India
ovartis Healthcare Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: H55-H57- Other disorders of eye and adnexa
- Sponsor
- ovartis Healthcare Pvt Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed nAMD patients
- •Patients (male or female) aged \>\=50 years of age at Index date
- •Patients diagnosed with nAMD in at least one eye
- •Patients with VA/OCT assessments at both baseline, Month 12 and Month 24
- •Patients treated with intravitreal injection of anti\-VEGF (received at least one anti\-VEGF injection during the post\-index follow\-up period and at least 2 visits with OCT in between Months 0\-12\).
- •Patients with minimum follow\-up period of 24 months. (received at least one anti\-VEGF injection and at least 1 visit with OCT in between Months 13\-24\)
Exclusion Criteria
- •Patients with dry AMD, geographic atrophy and other retinal diseases
- •Patients who were part of any other trial/ study
- •Patients undergoing additional ocular treatment along with Anti VEGF agents will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Standardised Treatment And Monitoring Protocol to assess safety and tolerability of phage therapy in adults and children (STAMP study)Bacterial infectionsInfection - Other infectious diseasesACTRN12621001526864Western Sydney Local Health District50
Recruiting
Phase 1
Corneal injury treatment protocol using 50% Autologous Serum Eye DropsRBR-34d3jv2niversidade Federal de São Paulo - UNIFESP/EPM
Not yet recruiting
Phase 4
To compare the effect of spinal anaesthesia and general anaesthesia on blood glucose levels in lower abdominal surgeriesCTRI/2024/05/068062Department of Anaesthesiology
Completed
Phase 4
An Observational study to check safety and effectiveness of CASIRIVIMAB/ IMDEVIMAB treatment of mild/moderate covid 19 patients in IndiaHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2021/06/034375Roche Products India Pvt Ltd200
Active, not recruiting
Not Applicable
Protocol for a platform trial of interventions to equitably improve access to community eye services in Botswana, India, Kenya and Nepalndifferentiated eye problems identified by community-based screeners using the Peek Vision screening app.Eye DiseasesISRCTN53970958ondon School of Hygiene & Tropical Medicine10,000